Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer.

MLA

Ghasemi, Farhad, et al. “Repurposing Albendazole: New Potential as a Chemotherapeutic Agent with Preferential Activity against HPV-Negative Head and Neck Squamous Cell Cancer.” Oncotarget, vol. 8, no. 42, Apr. 2017, pp. 71512–19. EBSCOhost, https://doi.org/10.18632/oncotarget.17292.

APA

Ghasemi, F., Black, M., Vizeacoumar, F., Pinto, N., Ruicci, K. M., Le, C. C. S. H., Lowerison, M. R., Leong, H. S., Yoo, J., Fung, K., MacNeil, D., Palma, D. A., Winquist, E., Mymryk, J. S., Boutros, P. C., Datti, A., Barrett, J. W., & Nichols, A. C. (2017). Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer. Oncotarget, 8(42), 71512–71519. https://doi.org/10.18632/oncotarget.17292

Chicago

Ghasemi, Farhad, Morgan Black, Frederick Vizeacoumar, Nicole Pinto, Kara M Ruicci, Carson Cao Son Huu Le, Matthew R Lowerison, et al. 2017. “Repurposing Albendazole: New Potential as a Chemotherapeutic Agent with Preferential Activity against HPV-Negative Head and Neck Squamous Cell Cancer.” Oncotarget 8 (42): 71512–19. doi:10.18632/oncotarget.17292.